Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma

Clinical and Experimental Metastasis

Volumn 32, Issue 7, 2015, Pages 739-753

  Morita, Yoshihiro ^a,b   Hata, Kenji ^a   Nakanishi, Masako ^a   Omata, Tetsuji ^c   Morita, Nobuo ^b,c,d   Yura, Yoshiaki ^a   Nishimura, Riko ^a   Yoneda, Toshiyuki ^a,e  

^a OSAKA UNIVERSITY   (Japan)

^b Seichokai Hannan Municipal Hospital   (Japan)

^c Kinan Hospital   (Japan)

^d NS Medical Healthcare Service General Incorporation Foundation   (Japan)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Differential metastasis array; E cadherin; Epithelial mesenchymal transition; Focal adhesion kinase; Short hairpin RNA

Indexed keywords

FIBRONECTIN; FIBRONECTIN 1; FOCAL ADHESION KINASE; G PROTEIN COUPLED RECEPTOR 54; SHORT HAIRPIN RNA; STROMELYSIN; STROMELYSIN 2; TRANSIENT RECEPTOR POTENTIAL CHANNEL M1; UNCLASSIFIED DRUG; VASCULOTROPIN C; FN1 PROTEIN, HUMAN;

ARTICLE; CANCER PATIENT; CANCER SURVIVAL; COMPARATIVE STUDY; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MOUTH SQUAMOUS CELL CARCINOMA; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL INOCULATION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; FLUORESCENT ANTIBODY TECHNIQUE; HEAD AND NECK TUMOR; METABOLISM; MOUSE; MOUTH TUMOR; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE; HEAD AND NECK NEOPLASMS; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MICE; MICE, NUDE; MOUTH NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84942363603     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-015-9741-2     Document Type: Article

References (55)

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300
2. Matsuda A, Matsuda T, Shibata A et al (2014) Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 44:388–396
3. Hunter KD, Parkinson EK, Harrison PR (2005) Profiling early head and neck cancer. Nat Rev Cancer 5:127–135
4. Forastiere A, Koch W, Trotti A, Sidransky D (2001) Head and neck cancer. N Engl J Med 345:1890–1900
5. Gil Z, Carlson DL, Boyle JO et al (2009) Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer 115:5700–5710
6. Mamelle G, Pampurik J, Luboinski B et al (1994) Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg 168:494–498
7. Joukov V, Pajusola K, Kaipainen A et al (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:1751
8. Mandriota SJ, Jussila L, Jeltsch M et al (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20:672–682
9. Stacker SA, Caesar C, Baldwin ME et al (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7:186–191
10. Skobe M, Hawighorst T, Jackson DG et al (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192–198
11. Sleeman JP, Thiele W (2009) Tumor metastasis and the lymphatic vasculature. Int J Cancer 125:2747–2756
12. Makinen T, Veikkola T, Mustjoki S et al (2001) Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 20:4762–4773
13. Veikkola T, Jussila L, Makinen T et al (2001) Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 20:1223–1231
14. Roberts N, Kloos B, Cassella M et al (2006) Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res 66:2650–2657
15. Burton JB, Priceman SJ, Sung JL et al (2008) Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Cancer Res 68:7828–7837
16. Alitalo K, Carmeliet P (2002) Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1:219–227
17. Dadras SS, Paul T, Bertoncini J et al (2003) Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 162:1951–1960
18. Karpanen T, Alitalo K (2001) Lymphatic vessels as targets of tumor therapy? J Exp Med 194:F37–F42
19. Morita Y, Morita N, Hata K et al (2014) Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-c and lymph node metastasis in human oral tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol 117:502–510
20. Yanase M, Kato K, Yoshizawa K et al (2014) Prognostic value of vascular endothelial growth factors A and C in oral squamous cell carcinoma. J Oral Pathol Med 43:514–520
21. Morita Y, Hata K, Nakanishi M et al (2012) Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma. Int J Oncol 41:885–892
22. Takahashi K, Kanazawa H, Akiyama Y et al (1989) Establishment and characterization of a cell line (SAS) from poorly differentiated human squamous cell carcinoma of the tongue. Jpn Stomatol Soc 38:20–28
23. Harada M, Miyata K, Wada T et al (1993) Establishment and characterization of a cell line(Sa3) from squamous cell carcinoma of the human gingiva. Japanese J Oral Maxillofac Surg 39:965–971
24. Horikoshi M, Kimura Y, Nagura H et al (1974) A new human cell line derived from human carcinoma of the gingiva. I. Its establishment and morphological studies. Nihon Koku Geka Gakkai Zasshi 20:100–106
25. Cailleau R, Young R, Olivé M, Reeves WJ (1974) Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53:661–674
26. Yoneda T, Williams PJ, Hiraga T et al (2001) A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 16:1486–1495
27. Iwata C, Kano MR, Komuro A et al (2007) Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. Cancer Res 67:10181–10189
28. Hata K, Nishimura R, Ueda M et al (2005) A CCAAT/enhancer binding protein beta isoform, liver-enriched inhibitory protein, regulates commitment of osteoblasts and adipocytes. Mol Cell Biol 25:1971–1979
29. Qi W, Chen X, Gilbert RE et al (2007) High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1. Am J Pathol 171:744–754
30. Cabrita MA, Jones LM, Quizi JL et al (2011) Focal adhesion kinase inhibitors are potent anti-angiogenic agents. Mol Oncol 5:517–526
31. Zhao J, Guan J-L (2009) Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev 28:35–49
32. Takeshita A, Iwai S, Morita Y et al (2014) Wnt5b promotes the cell motility essential for metastasis of oral squamous cell carcinoma through active Cdc42 and RhoA. Int J Oncol 44:59–68
33. Berrier AL, Yamada KM (2007) Cell-matrix adhesion. J Cell Physiol 213:565–573
34. Hu M, Carles-Kinch KL, Zelinski DP, Kinch MS (2004) EphA2 induction of fibronectin creates a permissive microenvironment for malignant cells. Mol Cancer Res 2:533–540
35. Zheng Y, Ritzenthaler JD, Roman J, Han S (2007) Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression. Am J Respir Cell Mol Biol 37:681–690
36. Ritzenthaler JD, Han S, Roman J (2008) Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling. Mol BioSyst 4:1160–1169
37. Pankov R, Yamada KM (2002) Fibronectin at a glance. J Cell Sci 115:3861–3863
38. Mitra AK, Sawada K, Tiwari P et al (2011) Ligand-independent activation of c-Met by fibronectin and α(5)β(1)-integrin regulates ovarian cancer invasion and metastasis. Oncogene 30:1566–1576
39. Scanlon CS, Van Tubergen EA, Inglehart RC, D’Silva NJ (2013) Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. J Dent Res 92:114–121
40. Tsai JH, Yang J (2013) Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev 27:2192–2206
41. Guarino M, Rubino B, Ballabio G (2007) The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39:305–318
42. Gupta GP, Massagué J (2006) Cancer metastasis: building a framework. Cell 127:679–695
43. Yoo JS, Kim HB, Won N et al (2011) Evidence for an additional metastatic route: in vivo imaging of cancer cells in the primo-vascular system around tumors and organs. Mol Imaging Biol 13:471–480
44. Margadant C, van den Bout I, van Boxtel AL et al (2012) Epigenetic regulation of galectin-3 expression by β1 integrins promotes cell adhesion and migration. J Biol Chem 287:44684–44693
45. Park J, Schwarzbauer JE (2014) Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition. Oncogene 33:1649–1657
46. Yang J, Mani SA, Donaher JL et al (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:927–939
47. Van Obberghen-Schilling E, Tucker RP, Saupe F et al (2011) Fibronectin and tenascin-C: accomplices in vascular morphogenesis during development and tumor growth. Int J Dev Biol 55:511–525
48. Jerhammar F, Ceder R, Garvin S et al (2010) Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma. Cancer Biol Ther 10:1244–1251
49. Avraamides CJ, Garmy-Susini B, Varner JA (2008) Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer 8:604–617
50. Garmy-Susini B, Avraamides CJ, Schmid MC et al (2010) Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis. Cancer Res 70:3042–3051
51. Steffens S, Schrader AJ, Vetter G et al (2012) Fibronectin 1 protein expression in clear cell renal cell carcinoma. Oncol Lett 3:787–790
52. Takeyama H, Kyoda S, Okamoto T et al (2011) The expression of sialic fibronectin correlates with lymph node metastasis of thyroid malignant neoplasmas. Anticancer Res 31:1395–1398
53. Sudo T, Iwaya T, Nishida N et al (2013) Expression of mesenchymal markers vimentin and fibronectin: the clinical significance in esophageal squamous cell carcinoma. Ann Surg Oncol 20(Suppl 3):S324–S335
54. Kamarajan P, Garcia-Pardo A, D’Silva NJ, Kapila YL (2010) The CS1 segment of fibronectin is involved in human OSCC pathogenesis by mediating OSCC cell spreading, migration, and invasion. BMC Cancer 10:330
55. Lyons AJ, Bateman AC, Spedding A et al (2001) Oncofetal fibronectin and oral squamous cell carcinoma. Br J Oral Maxillofac Surg 39:471–477